"Basically, we have two types of production arrangements. So Russian manufacturing capabilities will mostly be producing for Russia ...We will produce 4 million doses for 2 million people already in December," Dmitriev said during an online panel about the vaccine.
"We will be producing tens of millions of doses of the vaccine already starting from February in four key geographies - it's India, Brazil, China, Korea and Argentina. We already reached supply agreement and production agreement with those countries for 500 million doses of the vaccine from next year. So starting from March, we will be able to produce more than 30 million doses a month and we are working to increase our production capacity even further. When I talk [about] 30 million doses a month, I talk about 30 million people, so in the pharma lingo it's called 60 million doses a month," Dmitriev said.